Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-01-20

Clinical Trial Update: A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine (0462-087) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Rizatriptan for the treatment of acute migraine has completed and its results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rizatriptan (Rizatriptan)

Snippet

Sponsor: Organon and Co | Conditions: Acute Migraine | Phase 3 | Status: COMPLETED | Results posted: 2011-01-20